Overview

Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of QVA149 in patients with moderate to severe COPD.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Glycopyrrolate